Hard to compare complexity of Biotron assays to Immuron etc. along with taking into account 6 months of treatment plus several weeks follow-up post-dosing. I don't know the detail around Immuron trials however Biotron are analysing three very complex, data-heavy Phase 2 trials all at once.
Hard to compare complexity of Biotron assays to Immuron etc....
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $43.30M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $13.69K | 278.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 46070 | 1 |
View Market Depth
| Last trade - 15.37pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
-0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.9¢ | 5.0¢ | 4.9¢ | 61814 | ||
| Last updated 13.21pm 17/06/2024 ? | |||||
| BIT (ASX) Chart |
